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Introduction
Aspirate and bone marrow biopsy are diagnostic methods used in 
the study of hematological diseases allowing molecular, cytogenetic, 
and immunophenotype analyses, indispensable today for the 
classification of hematolymphoid malignancies. Its indications are 
ample and include various types of hematolymphoid malignancies, 
solid tumors, study of fever of unknown origin, and other infiltrative 
diseases. Trained physicians must perform these procedures in order 
to recognize indications and medical risks related with the procedure 
and also managing potential complications.1 This study can be realized 
on an outpatient procedure room or during hospitalization. For patient 
convenience, biopsies are usually made in the posterior iliac crest.2 
Nevertheless, pain is a common outcome after this kind of 
procedures. In the UK the use of local anesthetic and benzodiazepines 
(midazolam), as a pain management strategy is common during this 
process, achieving better grief control.3,4 Furthermore, other strategies 
for deep sedation are also used, such as ketamine or propofol, these 
being more morbid by a high risk of respiratory depression, aspiration, 
hemodynamic instability, arrhythmias, and cardiac arrest.5
While there are several factors that are associated with the onset of 
pain as gender, race, body mass index and duration of the procedure, it 
is clear that anxiety plays an important role related to pain control after 
the procedure. Therefore, giving prior information, solve hesitations 
adequately and reassure the patient is used as a non-pharmacological 
pain control strategy.6
In the Hospital of San José (Bogotá, Colombia) as part of the 
quality management of the institution, there is a monitoring program 
after invasive procedures called Group of Education and Monitoring 
of Egress (GESE). This program offers comprehensive, emotional 
orientation, safe, continuous, and quality care, ensuring adherence to 
the home care plan. The scope includes patients who have undergone 
surgery in all specialties of the hospital, in our specific patients whose 
were undergone bone marrow biopsy and aspiration.7
Several case reports of complications related to the realization of 
bone marrow aspiration and biopsy had been published, it is worth 
highlighting studies such as the ones performed by Barbara J. Bain in 
collaboration with the British Society of Hematology, which analyze 
morbidity and mortality in terms of frequency and causal relationship 
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Abstract
Background: Bone marrow aspiration and biopsy are diagnostic methods in the 
study of hematological diseases. Complications are rare. Knowing the morbidity 
and mortality related to the procedure is essential in order to implement preventive 
behaviors and improvement plans. 
Objective: To determine the incidence of complications in patients over 18 years 
who were undergone to bone marrow biopsy and aspiration in a university hospital 
between October 2013 and May of 2015. Furthermore, frequency, socio-demographic 
and clinical characteristics were established as well.
Materials & methods: Observational, descriptive and retrospective study. The unit 
of analysis was biopsies and bone marrow aspirations. The information was obtained 
from the database of outpatient hematology ward, into the program Group of Education 
and Monitoring of Egress (GESE) of the Hematology Service of Hospital de San José 
(Bogotá, Colombia), and from medical records.
Results: A total of 1252 bone marrow aspirates and biopsies were performed on 914 
patients. Seventy-seven complications were reported, which corresponds to 6.15% of 
all documented procedures. The most frequent complication was: pain (100%), being 
more affected the women (66%), OR 1,91(IC 1,18-3,11) p=0,003. Regard to pathology 
diagnosis, 53.2% of biopsies were histologically normal hematopoiesis, followed 
by 16.8% for chronic myeloproliferative syndromes, which was the diagnosis most 
commonly associated with bleeding events (40%):OR 8,9 (IC 1,2-66,44) p=0,006, and 
death (1.3%).
Conclusion: Pain was the most frequently reported complication, and among bleeding 
complications, chronic myeloproliferative disorders were the most common diagnosis. 
The largest number of complications in women may be related to the anatomical 
differences between the genders. It is recommended to improve post-procedure 
analgesia and prospective studies to establish association between complications and 
diagnosis.
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